The table below shows Tango Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$53.81M
$3.18M
$5.39M
$11.61M
$19.88M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$33.53M
$30.82M
$32.81M
$36.44M
$33.26M
$38.65M
SG&A
TNGX annual revenue (10-K history)
Tango Therapeutics, Inc. reported annual revenue of $62.38M for fiscal year 2025. That is up 48.3% from $42.07M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $7.66M (FY 2020) to $62.38M. Figures come from the company's audited annual reports as filed with the SEC.